Answers are grounded in this paper and cite their sources.
Objective To evaluate serum Galectin-3 levels in patients with non-muscle-invasive bladder cancer (NMIBC) and to investigate their diagnostic performance and ability to discriminate between low-grade and high-grade disease. Methods This prospective controlled study included 80 patients with NMIBC (40 low-grade and 40 high-grade) and 40 age-matched healthy controls. Serum Galectin-3 levels were measured using a commercially available ELISA kit prior to transurethral resection of the bladder tumor. Group comparisons were performed using appropriate parametric and non-parametric statistical tests. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis with bootstrap confidence intervals and internal five-fold cross-validation. Associations between serum Galectin-3 levels and bladder cancer diagnosis and high-grade disease were assessed using univariate logistic regression. Results Serum Galectin-3 levels differed significantly among the study groups, with the highest levels observed in patients with high-grade NMIBC ( P < 0.01). No significant difference was observed between the low-grade and control groups. Galectin-3 demonstrated moderate discrimination between patients with NMIBC and healthy controls (AUC = 0.673), whereas discrimination between high-grade and low-grade NMIBC was more pronounced (AUC = 0.777). Higher serum Galectin-3 levels were associated with bladder cancer diagnosis (OR 1.216, 95% CI, 1.003–1.475, P = 0.046) and with high-grade disease (OR 1.493, 95% CI, 1.097–2.033, P = 0.011). Conclusion Serum Galectin-3 appears to be associated primarily with high-grade tumor biology rather than with the presence of NMIBC itself. Although its overall diagnostic performance for detecting NMIBC is moderate, it may serve as a complementary biomarker for discriminating high-grade disease. External validation in larger multicenter cohorts is required before clinical application.
No takes yet. Share an insight, caveat, or question.
Eryılmaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: